Schedule 13G ownership disclosure
CARTESIAN THERAPEUTICS INC
Security class unavailable · CUSIP: 816212104
Event date: 2017-06-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,119,189
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001615774-17-003435
- Form type
- SC 13G
- Filer
- Cartesian Therapeutics, Inc.
- CIK
- CIK 1453687
- Filed
- Jun 30, 2017
- Reporting period
- Jun 26, 2017
- Description
- Schedule 13G beneficial ownership